Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)
China · Delayed Price · Currency is CNY 17.86
+0.20 (1.13%)
Feb 3, 2026, 2:55 PM CST
SHA:603456 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 722.87 | 606.1 | 1,033 | 921.17 | 633.9 | 380.58 |
Depreciation & Amortization | 401.53 | 401.53 | 381.82 | 348.2 | 292.08 | 252.31 |
Other Amortization | 11.67 | 11.67 | 1.86 | 1.76 | 0.26 | 0.48 |
Loss (Gain) From Sale of Assets | 3.16 | 3.16 | 2.54 | 4.79 | 7.99 | 3.03 |
Asset Writedown & Restructuring Costs | 62.6 | 62.6 | 2.61 | 4.94 | 24.99 | 5.34 |
Loss (Gain) From Sale of Investments | 16.54 | 16.54 | 19.36 | 23.99 | -59.81 | -32.44 |
Provision & Write-off of Bad Debts | 16.65 | 16.65 | 19.38 | -5.71 | 7.56 | 6.46 |
Other Operating Activities | 713.46 | 142.26 | 82.14 | -7.29 | 78.53 | 103.38 |
Change in Accounts Receivable | -301.87 | -301.87 | -228.54 | 84.29 | -312.34 | -185.57 |
Change in Inventory | -121.13 | -121.13 | -9.39 | -386.67 | -510.21 | -364.55 |
Change in Accounts Payable | 148.13 | 148.13 | 14.46 | 194.44 | 492.07 | 205.45 |
Change in Other Net Operating Assets | 6.95 | 6.95 | 17.15 | 34.81 | -0.47 | - |
Operating Cash Flow | 1,680 | 991.66 | 1,360 | 1,226 | 677.52 | 400.39 |
Operating Cash Flow Growth | 93.27% | -27.10% | 10.98% | 80.92% | 69.21% | -27.75% |
Capital Expenditures | -579.93 | -888.96 | -929.44 | -713.79 | -579.88 | -315.73 |
Sale of Property, Plant & Equipment | 7.61 | 5.53 | 4 | 8.55 | 8.25 | 43.02 |
Cash Acquisitions | - | - | -113.34 | -31.28 | 34.67 | - |
Sale (Purchase) of Real Estate | - | - | - | - | -9.02 | - |
Investment in Securities | -97.96 | -5.4 | -41.27 | -6.79 | -279.99 | -10.83 |
Other Investing Activities | 7.46 | 7.51 | 23.25 | 4.89 | 60.53 | 73 |
Investing Cash Flow | -662.82 | -881.33 | -1,057 | -738.42 | -765.44 | -210.53 |
Long-Term Debt Issued | - | 1,627 | 2,113 | 923.89 | 1,446 | 1,833 |
Total Debt Issued | 470 | 1,627 | 2,113 | 923.89 | 1,446 | 1,833 |
Long-Term Debt Repaid | - | -1,635 | -2,059 | -1,290 | -1,686 | -1,768 |
Total Debt Repaid | -840.87 | -1,635 | -2,059 | -1,290 | -1,686 | -1,768 |
Net Debt Issued (Repaid) | -370.87 | -7.97 | 53.36 | -366.21 | -239.54 | 65.47 |
Issuance of Common Stock | - | - | 2,491 | 42.23 | 1,020 | 30.66 |
Repurchase of Common Stock | -30.45 | -30.45 | -1.25 | -1.73 | -1.29 | -9.39 |
Common Dividends Paid | -464.85 | -471.3 | -386.09 | -234.88 | -190.63 | -202.86 |
Other Financing Activities | -101.23 | -99.9 | -54.84 | -48.38 | -6.01 | - |
Financing Cash Flow | -967.4 | -609.61 | 2,102 | -608.96 | 582.43 | -116.12 |
Foreign Exchange Rate Adjustments | 19.67 | 16.89 | 7.6 | 57.61 | -22.59 | -51.49 |
Net Cash Flow | 69.08 | -482.39 | 2,413 | -63.99 | 471.92 | 22.25 |
Free Cash Flow | 1,100 | 102.69 | 430.88 | 511.99 | 97.64 | 84.67 |
Free Cash Flow Growth | - | -76.17% | -15.84% | 424.38% | 15.32% | -63.77% |
Free Cash Flow Margin | 20.53% | 1.99% | 7.80% | 9.40% | 2.40% | 3.20% |
Free Cash Flow Per Share | 1.25 | 0.12 | 0.48 | 0.62 | 0.12 | 0.10 |
Cash Income Tax Paid | 6.13 | -82.08 | -27.32 | -51.28 | -126.44 | -105.97 |
Levered Free Cash Flow | 1,038 | -54.69 | -376.18 | 397.76 | 238.83 | -257.43 |
Unlevered Free Cash Flow | 1,044 | -42.58 | -362.6 | 411.74 | 254.37 | -230.21 |
Change in Working Capital | -268.85 | -268.85 | -182.65 | -66.06 | -307.98 | -318.75 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.